title: Estrogenic influence on the regulation of hepatic estrogen receptor-alpha and serum level of angiotensinogen in female rats.
abstract: The majority of data regarding biological effects of estrogens is based on studies in male rats or ovariectomized (Ovx) female rats. Therefore, in this study, the effects of estradiol treatment on the regulation of the hepatic estrogen receptor and the level of circulating angiotensinogen were examined in the intact female rat. The data were compared with that of the hypophysectomized (Hx) rat. Animals were treated with either low (physiological) or high (pharmacological) doses of estrogen. In intact rats, the hepatic estrogen receptor (ER) level increased with increasing doses of estrogen. This was in contrast to the Hx rats where growth hormone (GH) and dexametasone (Dex) in combination were the sole modulators of the estrogen receptor. The angiotensinogen level increased in normal rats after estrogen administration in a dose dependent manner, regardless of the mode of administration. The pure antiestrogen ICI 182 780 efficiently blocked the increase in circulating angiotensinogen. The conclusion is that in the normal female, estrogens are important modulators of the serum angiotensinogen level.
authors.affiliation: Division for Reproductive Endocrinology L5:01, Department of Woman and Child Health, Karolinska Hospital, Karolinska Institutet, 171 76 Stockholm, Sweden. anneli.straveus-evers@kbh.ki.se
authors.forename: A
authors.initials: A
authors.lastname: Stavréus-Evers
authors.forename: P
authors.initials: P
authors.lastname: Parini
authors.forename: B
authors.initials: B
authors.lastname: Freyschuss
authors.forename: W
authors.initials: W
authors.lastname: Elger
authors.forename: G
authors.initials: G
authors.lastname: Reddersen
authors.forename: L
authors.initials: L
authors.lastname: Sahlin
authors.forename: H
authors.initials: H
authors.lastname: Eriksson
mesh_terms: D000808:Angiotensinogen / Q000097:blood; D000809:Angiotensins / Q000097:blood*; D000818:Animals; D003907:Dexamethasone / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D004965:Estrogen Antagonists / Q000494:pharmacology; D047628:Estrogen Receptor alpha; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D000077267:Fulvestrant; D005938:Glucocorticoids / Q000494:pharmacology; D013006:Growth Hormone / Q000494:pharmacology; D007124:Immunoenzyme Techniques; D017403:In Situ Hybridization; D008099:Liver / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D011863:Radioimmunoassay; D051381:Rats; D017207:Rats, Sprague-Dawley; D011960:Receptors, Estrogen / Q000096:biosynthesis* / Q000378:metabolism
chemical_list: D000809:Angiotensins; D004965:Estrogen Antagonists; D047628:Estrogen Receptor alpha; D004967:Estrogens; D005938:Glucocorticoids; D012333:RNA, Messenger; D011960:Receptors, Estrogen; D000808:Angiotensinogen; D000077267:Fulvestrant; D004958:Estradiol; D003907:Dexamethasone; D013006:Growth Hormone